VistaGen Therapeutics Inc (VTGN)

VistaGen Therapeutics Inc (VTGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.9M; returns 1 day -3.9%, 1 week -10.2%, 1 year -95.7%.

VistaGen Therapeutics Inc. (VTGN) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for psychiatric and neurological disorders.

Groups VTGN belongs to

• Clinical Stage Biopharma
• Biotechnology
• Pharmaceuticals
• Neuroscience
• CNS Disorders
• Healthcare
• Mental Health Solutions
• Neurological Disorders
• Biopharmaceutical
• Clinical Stage
• Unmet Medical Needs

VTGN financial model: income statement, cash flow and balance sheet